Recently, it was shown by Chen et al. that serum ITIH5 levels are considerably elevated in cholangiocarcinoma compared to controls (i.e., hepatocellular carcinoma, benign disease, chronic hepatitis B and healthy individuals) [32]. Here, ITIH5 is linked to hepatocellular carcinoma.